Oppenheimer Cuts Price Target as Gilead Sciences (GILD) Reports 1Q Miss
Tweet Send to a Friend
Oppenheimer maintained an Outperform rating on Gilead Sciences (NASDAQ: GILD), and cut the price target to $116.00 (from $120.00), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
